Opus Genetics IRD
NASDAQ IRD
$4.86 -0.09 (-1.82%)
As of: Sep 30, 2026 · 3:52 PM EDT

Opus Genetics (IRD) Interest Expenses (2020 - 2026)

Updated

Opus Genetics' Interest Expenses was $69,000 in Q1 2026, up 13.1% from the prior quarter.

Analysis

Opus Genetics (IRD) Interest Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Opus Genetics' Interest Expenses was $198,000 through Mar 31, 2026; for FY2025, it was $129,000.

  • Interest Expenses shows a five-year compound annual growth rate of -54.8% (FY2020 to FY2025).
  • In earlier years, Interest Expenses was $9,000 in FY2022 (+350.0%) and $2,000 in FY2021 (-100.0%).
  • The Q1 2026 figure marks the highest quarterly Interest Expenses since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 281.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -435.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Opus Genetics 409.11 Mn 184.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 69,000.00
Dec 31, 2025 61,000.00
Sep 30, 2025 68,000.00
Jun 30, 2022 4,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 2,000.00
Dec 31, 2020 5.43 Mn
Sep 30, 2020 179,000.00
Jun 30, 2020 689,000.00
Mar 31, 2020 554,000.00
API Access

Opus Genetics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IRD&period=max&api_key=YOUR_API_KEY